S100A9 and congenital rubella syndrome: During CRS, psoriasin and calgranulins (S100A8, S100A9, and S100A12), which are known for their chemo-attractive properties to immune cells, increased pro-inflammation and triggered proliferation via TLR-4 and RAGE [151,152].